RT for DCIS Ups Mortality Risk in Invasive Second Breast Cancer
Rates of mortality for invasive second breast cancer higher in those with prior radiotherapy for DCIS.
Rates of mortality for invasive second breast cancer higher in those with prior radiotherapy for DCIS.
This study examined the risk of secondary cancers among patients with CML who were treated with TKIs.
Hodgkin lymphoma survivors are at higher risk of second cancers, and that risk is even higher in those with a first-degree relative with cancer.
Nearly 1 in 12 patients with a cancer from the 10 most common cancer sites developed a second primary neoplasm during survivorship.
Review found increased odds for developing thyroid or breast cancer as secondary malignancy after the other cancer type was diagnosed.
Lifelong screening is recommended for survivors of childhood cancer that affects the vision, in order to detect issues early.
Hodgkin lymphoma survivors have an increased risk of secondary cancer compared with the general population, even for those receiving more recent treatments.
The discovery of an enzyme that facilitates the spread of breast cancer may enable clinicians to prevent secondary cancer.
[Cancer Management and Research] Secondary cancer risk following radiotherapy is an increasingly important topic in clinical oncology with impact on treatment decision making and on patient management.
Compared to patients who were treated with surgery alone